Physician profile
Parimalkumar Chaudhari
NPI 1689958266
$1,649.65
in general payments reported to CMS, 2019-2025
20 companies · $73.78 in 2025
The $73.78 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $664 · 2020: $184 · 2021: $288 · 2022: $79.10 · 2023: $245 · 2024: $115 · 2025: $73.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.33 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $463.05 | 2019-2025 | Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $398.66 | 2019-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.45 | 2019-2021 | |
| Philips North America LLC | $125.83 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $91.31 | 2019-2023 | Dupixent |
| Genzyme Corporation | $48.48 | 2019 | |
| Baxter Healthcare | $46.51 | 2024 | Hillrom - Monarch Airway Clearance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.53 | 2019 | |
| Pulmonx Corporation | $44.38 | 2023 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Grifols USA, LLC | $34.70 | 2019-2020 | |
| Insmed, INC. | $33.62 | 2022-2025 | Brinsupri |
| Inspire Medical Systems, INC. | $29.35 | 2023-2024 | Inspire |
| Abiomed | $25.76 | 2023 | Impella |
| Circassia INC. | $25.45 | 2019 | |
| Mylan Specialty L.P. | $22.00 | 2024 | Yupelri |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $20.57 | 2020 | |
| Acacia Pharma INC | $19.77 | 2021 | |
| Amgen INC. | $15.65 | 2019 | |
| Resmed Corp | $14.54 | 2023 | |
| Genentech USA, INC. | $14.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parimalkumar Chaudhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.